Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

March 13, 2024

New York Stock Exchange US Materials Chemicals earnings 31 min

Earnings Call Speaker Segments

Mike Critelli

executive
#1

Thanks, and good morning to all of you. We're glad you could join us for Flotek's conference call covering fourth quarter and full-year 2023 results. With me today are Ryan Ezell, our Chief Executive Officer, and Bond Clement, our Chief Financial Officer. During this call, we'll begin with prepared comments about the business and our results for the fourth quarter and full-year 2023. After those remarks, we'll take whatever questions you may have. Flotek's press release on fourth quarter and full-year 2023 earnings came out yesterday afternoon. An updated corporate presentation that we'll refer to today is also posted; both documents are available in the Investor Relations section of our website. Today's call is also being webcast, and once it concludes, a replay will be accessible on our website. Please be aware that anything said today about projections or expectations for future events constitutes forward-looking statements. Such statements carry a number of risks and uncertainties, many beyond our control. Actual results could differ materially from our current expectations because of these risks and uncertainties. We encourage listeners to review our earnings release and the risk factors described in our SEC filings; we also ask you to refer to the reconciliations included in the earnings press release and corporate presentation, since management may discuss non-GAAP metrics on this call. With that, I'll hand things over to our CEO, Ryan Ezell.

Ryan Ezell

executive
#2

Thank you, Mike, and good morning. We’re grateful for everyone’s interest in Flotek and for being with us today as we go over our operational and financial results for the 4th quarter and full-year 2023. I’m very pleased with what we achieved, because 2023 was genuinely a transformational year: we brought profitability back across all key financial metrics, improved our liquidity, and made our leadership team stronger by executing our corporate strategy with chemistry as the shared platform for value creation. With an unwavering emphasis on technology, we continue to lead in innovation and multidisciplinary advances that keep driving market-share gains through our differentiated chemistry and data analytics solutions. Each offers a clear value proposition that maximizes our customers’ value chain while producing a meaningful return on investment for shareholders. With that in mind, let me turn to slide 7 and highlight our key 2023 accomplishments, which Bond will cover in detail shortly. We posted strong year-over-year growth across all key profitability metrics, including gross profit, adjusted gross profit, and Adjusted EBITDA; Adjusted EBITDA for the fourth quarter of 2023 marked the 10th consecutive quarter of improvement, and full-year 2023 was our best year in nearly a decade. Total company revenue rose 38% versus 2022 as we sold the largest volume of products in the company’s history. Chemistry revenues from external customers increased in each quarter of the year and were up more than 21% versus 2022, driven by our rapidly expanding customer base and continued adoption of our prescriptive chemistry management business model. Our customized engineering approach, together with our proprietary complex nanofluid technologies, continues to produce wells that outperform adjacent competitor wells across all basins. Our data analytics revenue grew strongly, up 47% in 2023 versus 2022. Subscription-based revenue in that segment has increased 250% since 2022, supporting our strategy to move toward a data-as-a-service business model. These subscription-based services have achieved a 95% annualized retention rate. We also widened our global footprint through the successful commercial launch of our slickwater fluid systems in the Kingdom of Saudi Arabia and by establishing a new entity in Abu Dhabi to support diversified market-share growth and margin expansion internationally. We also recently announced that Amy Blakeway has joined our senior leadership team as Senior Vice President and General Counsel. She will be an asset to the organization, bringing extensive sector experience and joining at a pivotal moment as we seek to capitalize on both organic and inorganic growth opportunities. Most importantly, we achieved all of this with zero recordable and lost-time incidents in the field of operations, extending the current streak to more than 753 days without a recordable incident. I want to take a moment to thank every one of our employees for their dedication to safety and to service quality in delivering these exceptional results, and I anticipate that we will keep building on this momentum all through 2024. Turning now to the quarter with a little more detail, revenue came in slightly lower on a sequential basis; that dip reflects the fact that overall markets decelerated in upstream onshore activity seen during this year as natural gas keeps confronting near-term pressure on pricing. Even with that pullback in drilling and completion activity overall, the effect on Flotek has been considerably smaller thanks to how we have executed our strategy centered on our differentiated and complementary chemistry and data technologies. Along those lines, we have kept growing revenues from our external chemistry business in each quarter of this year, and they rose by another 10% during the 4th quarter. Even more significant, we recorded a 75% rise in sales of our reservoir-centric technology tied to complex nanofluids. In addition, the chemistry purchase obligations written into the long-term supply agreement with ProFrac were structured to soften market volatility and give Flotek operations a degree of insulation so we can preserve economies of scale and stability. We anticipate continued growth in reservoir-centric and international chemistry revenues, which ought to help counterbalance the headwinds from a slowing upstream completion environment. At a broader macro level, demand for oil and gas is projected to grow over the next decade, with additional requirements through 2045. Sustained investment across both short and long-barrel cycles will be needed to keep production up and supply the necessary incremental volumes. Notwithstanding near-term swings in commodity pricing, the fundamentals for energy-related services stay solid. Continued expansion of the global economy will keep generating considerable demand for every form of energy, which will drive greater service intensity across the sector. As we look toward 2024, our focus stays sharply fixed on growing revenue, expanding market share, and capturing cost-efficiency gains, since we are well-positioned to take advantage of opportunities both at home and abroad. Wider adoption of our prescriptive chemistry management for better reservoir performance, together with the launch of the next-generation JP3 measurement system, opens up meaningful upstream market opportunities, as the company expects the data analytics business to expand by 50% in 2024. We are confident that our growing suite of services puts us in position to deliver distinctive and superior solutions that maximize our customer's value chain. In line with this outlook, we believe demand for our advanced chemistry and data solutions will keep rising and will open new opportunities in market verticals including industrial, geothermal, agricultural, solar, and hydrogen. I'll now hand the call to Bond for the key financial highlights.

Bond Clement

executive
#3

Thanks, Ryan, and good morning, everyone — appreciate you being here. By just about any yardstick, 2023 was an excellent year for us: we got the company back to profitability and posted meaningful gains across every key financial measure. I share Ryan's view on these exceptional results, and I know everyone on the Flotek team takes pride in what we've achieved — not just in 2023, but across the past two years. The turnaround work Flotek has executed has put us in a far stronger financial position than we were a year ago, and we plan to keep building on that momentum through 2024. As evidence of that stronger financial footing, I'm pleased to say our 2023 10-K filing will confirm that the going concern doubt our auditors raised in their 2022 audit is now resolved; on top of that, we expect our 2023 10-K to report that the internal control weaknesses disclosed in last year's 10-K have been remediated. Let me walk through a handful of key financial items for the 4th quarter and the full year of 2023. I'll be referencing slides from the presentation we posted to the website yesterday. Slide 7 lays out our accomplishments and the strong financial growth delivered across the business — the headline numbers were annual improvements of $52 million in revenue, $31 million in gross profit, and $28 million year-over-year in Adjusted EBITDA. On Adjusted EBITDA, we posted yet another quarterly improvement in the 4th quarter, which marks two and a half years of sequential gains in that metric. Even more important, as Ryan noted earlier, full-year 2023 Adjusted EBITDA was positive for the first time since 2017. Moving to the income statement on slide 8, we've achieved sustained revenue growth since 2021, with our 2023 increases coming from both the chemistry and data analytics segments. Full-year 2023 revenues grew 38% over 2022, even with lower North American land completion activity in the second half of the year. Chemistry revenue from external customers rose 21% during the year. What's more impressive, though, is the comparison of the 4th quarter of 2023 with the 1st quarter of 2023, when revenue from external customers increased by 100%. Beyond our success growing the chemistry business, we also generated strong growth from the data analytics segment, with revenues associated with JP3 up 47% over 2022 and up almost 90% since 2021. On slide 9, 4th quarter gross profit rose for the 4th consecutive quarter as we continued delivering efficiencies throughout every aspect of the business supply chain. 4th quarter gross profit grew to over $9 million, compared with a gross loss of $2 million in the comparable 2022 period. For the full year 2023, we reported gross profit of $24 million versus a gross loss of $7 million last year, as the company benefited from the many cost improvements implemented during the year. Turning to slide 10, Adjusted EBITDA improved 17% sequentially from the 3rd quarter of 2023, with that metric totaling $4 million. Like I mentioned before, this marks the 10th straight quarter where things have gotten better, and that run stretches all the way back to Q2 of 2021. Turning to SG&A, the 4th quarter came in at $6.6 million, versus $6.2 million in last year's 4th quarter. For all of 2023, SG&A was $27.9 million, compared with $27.1 million across full-year 2022. Measured as a share of revenue, SG&A for 2023 fell 500 basis points relative to 2022; worth pointing out is that both the 4th quarter and the full-year figures for 2022 contained a $1.9 million credit tied to reversing a bonus accrual. If you strip out that credit's benefit, SG&A for the 4th quarter of 2023 and for all of 2023 came in 18% and 4% lower, respectively, than the 2022 periods. Down at the bottom line, we posted net income of $2.1 million in Q4 of 2023, against a net loss of $19 million in Q4 of 2022. Full-year 2023 net income reached $24.7 million, versus a net loss of $42.3 million for 2022. The 2023 net income figure did include a $30 million non-cash gain stemming from fair value measurement of our convertible notes. Those notes matured in 2023, so we don't anticipate that kind of earnings volatility ahead. On the balance sheet, back in October we announced an increase in credit availability under the ABL, from $10 million up to $13.8 million. At year-end, we had $7.5 million drawn on the ABL. As of Monday, the amount drawn was under $1 million. Finally, we plan to give 2024 guidance alongside our first quarter results in May. That mirrors what we did last year, when guidance also came out with the first quarter 2023 results. Although no formal guidance is being offered right now, we do expect positive Adjusted EBITDA in each quarter of 2024, and we expect that to deliver another year of strong growth in that metric. To wrap up, Flotek keeps producing strong, repeatable results with profitability as the priority. We look for additional revenue growth in 2024, and we'll stay sharply focused on cutting costs wherever possible, especially SG&A. I'll hand the call back to Ryan now for closing remarks.

Ryan Ezell

executive
#4

Thanks, Bond. If you turn to slide 17, 2024 is something we're really enthusiastic about, since there's enormous growth potential across both our chemistry and data analytics segments, and we feel Flotek offers an attractive investment opportunity right now. Our 2023 results showed profitability, and we remain positioned for ongoing growth as the collaborative partner of choice for sustainable chemistry and data solutions. The progress we achieved in 2023 makes me proud, and I have confidence in our capacity to execute as we move ahead. We're grateful for all the continuing support from our stakeholders, and we hope you share our enthusiasm about Flotek's future; we look forward to reporting on additional progress. Operator, we're ready now to take questions.

Don Crist

analyst
#5

Morning, gentlemen. How’s everyone doing today?

Ryan Ezell

executive
#6

Don?

Bond Clement

executive
#7

Good morning, Don.

Don Crist

analyst
#8

I'd like to ask about JP3. You clearly included a great deal of detail in both the presentation and the press release; but regarding those pilot projects, could you provide some sort of projected timeline for when a few of them might come to fruition and when we can expect that revenue ramp-up? I know you emphasized 50% year-over-year, but when might we see a timeline of those events?

Ryan Ezell

executive
#9

Yes, Don, Ryan here. Looking at it at this moment, the major gating factor is getting the newer generation sensor into commercial application, which we expect at the end of H1; so we'll be anticipating a ramp-up in some of the revenue from these applications arriving in line during H2 of 2024 and carrying on through 2025 and beyond. A lot of that is driven by, when you consider the use of the Quad B and Quad C from the EPA on flare gas and then also some of the potential chain of custody measurements, many of those items will create some unique opportunities for us that unlock a $700+ million market TAM when we view it in terms of the upstream markets.

Don Crist

analyst
#10

All right. If we go one step further on that, and suppose you do capture the car bumper here, what sort of manufacturing capacity do you have on the sensor side to meet potential demand?

Ryan Ezell

executive
#11

Yes, that's an excellent question. And for us, I think that's the part we're most excited about. Our capabilities today would be moving up to roughly a 12x improvement in manufacturing velocity, in the sense that you'd look at what we would traditionally have moved in volume last year. With the improved manufacturing, we can move that in under a month now; so we've already got some preordered. We put some capital in upfront to go ahead and front-load these units, particularly the stuff we'll be using in the upstream piece, which for us will be on a data-as-a-service model, and went ahead and made those capital investments upfront. So we're really excited and confident that this manufacturing improvement, as well as the improvement in the analyzer performance, will be great for the company.

Don Crist

analyst
#12

All right. One more thing from my end. Over in Saudi, the chance on the slick water side — clearly, you just brought that up there. But considering their move toward gas drilling and more of what you'd call conventional shale drilling compared with what they've done before, what sort of opportunity set does that present to you as you go through 2024 and they become more at ease with the technology?

Ryan Ezell

executive
#13

On the whole, we've always had a footprint abroad; even so, I'd characterize it as a slice of total revenue that was fairly minor. But our plan of growing what we refer to as full-cycle chemistry sales meant that a varied business spanning global markets was very important to us — that's our spending on testing, which needed about 18 months before Aramco approved it, plus the work we did in Abu Dhabi. Looking at that system, the effect could, on a cautious estimate even, potentially double our international revenue compared with the prior year. I still believe that, looking at what we'll see happening in Saudi, it will matter a great deal to our international business, and it will be a big help.

Don Crist

analyst
#14

Thanks for that detail — I’ll rejoin the queue.

Ryan Ezell

executive
#15

All right. Thanks.

Jeff Robertson

analyst
#16

Thank you. Good morning. Ryan, on the.

Ryan Ezell

executive
#17

Good morning, Jeff.

Jeff Robertson

analyst
#18

Regarding the JP3, could you discuss what margins you might achieve as data-as-a-service adoption grows in that business? And second, when you collaborate with landowner groups on production allocations, how do you bring landowners and producers into agreement that the JP3 is the optimal measurement solution?

Ryan Ezell

executive
#19

There are a few points to address here. Starting with the margin profiles, we haven't provided full disclosure on what the margin profile for JP3 specifically looks like. What I can tell you is that when we model it into the data-as-a-service business, it delivers roughly a 15% improvement over the capital sale model across a three-year type period, along with the return on that. So it will lift, for us, not just our recurring revenue but the segment's overall profitability as well. If you look at what we're doing on the chain of custody side, that's a unique application, since there are thousands of wells for this kind of work. We've put an extensive amount of analysis into that. As a result, we're working with quite a few parties, especially if you consider some of the trust and some of the legal elements that actually handle processing of the royalties, etc., as part of chain of custody — those have been among the primary targets. Another unique aspect for us is that we've engaged with the Texas Railroad Commission, the Bureau of Land Management, and the EPA — different governing bodies — regarding how we manage this. Because make no mistake, in terms of how they measure quality today, they rely on a composite sample collected once every 6 to 9 months, and they'll be receiving this data every 10 seconds. So it will bring a significant change to how royalties are allocated and how the payments work. And so I think there will be a bit of movement in how this proceeds, and particularly at the gathering points and with the various trust, I believe, for doing a lot of the royalty allocations — that's where we'll see the first impact.

Bond Clement

executive
#20

Yes, Jeff, let me jump in with a quick addition. In my view, the operators along with the mineral owners will obviously be on the same page here on one side; and then the point where things start to clash, I believe, is in how the gathering companies or the first purchasers read the data that we provide and how they square those two things between an instantaneous continuous measurement point when it comes to assessing BTU quality versus, as Ryan mentioned, a single sample point every 30, 60, 90 days, depending on the circumstances? How do they reconcile the two so that every stakeholder gets paid the correct amount for what their product is worth?

Jeff Robertson

analyst
#21

Wouldn't a midstream gatherer who has a better sense of the BTU content coming toward them be able to process more efficiently as a result?

Ryan Ezell

executive
#22

Absolutely, 100%. Yes, 100%. And if you factor in what we can do with transmix, that makes it even stronger on that front.

Jeff Robertson

analyst
#23

Ryan, regarding chemistry, you've clearly had that ProFrac agreement in place for some time now. As you consider external chemistry, are you looking at the chance to shift it from a transactional business into more of a strategic alliance of some kind — perhaps even an alliance centered on a single basin with any of the pressure pumpers?

Ryan Ezell

executive
#24

That's a good additional point. Part of our broader strategy centers on that collaborative closeness with these customers. So as we've started to genuinely diversify how our revenue is structured, clearly, there's a 50/50 split between service companies and E&P operators. But to the point you raised, those ties with the E&P operators turn out to be extremely important when we consider our chemistry management and what we refer to as the external or transactional revenue stream, since we do establish long-term partnerships. And what we're beginning to observe is that they're getting much stickier in terms of performance, because they're starting to see the gains on the return on investment in the chemistry. And if you go out and examine much of the public space, particularly with some of the E&P operators, they're discussing how chemistry can unlock additional barrels from a reservoir across their various type curves. And so we serve as an essential component in that, not only delivering sustainable green technology, but also one that dramatically enhances reservoir performance. And so what they see is, in my view, that hands us a great opportunity for relationships with the EMP operators that are less volatile and longer-standing.

Jeff Robertson

analyst
#25

Finally, Ryan, regarding how your chemistry solutions affect well performance: as companies drill longer laterals, does that tend to boost demand for the kinds of chemistry solutions Flotek offers, in the sense of improving performance?

Ryan Ezell

executive
#26

I mean, it opens up a tremendous opportunity, because when you're drilling those longer laterals, we consider well spacing, we consider the overall fluid design — even down to how they drill them, the completion work they actually perform — all of that becomes extremely important, even the wellbore cleaning they look at before doing the actual frack. And so the earlier we get involved in the chain with our chemistry, we can match the clay control, the corrosion inhibition, the right surfactant technologies, or any solvents that need to be brought in, demulsification. So I think it's a tremendous opportunity. To me, once you get into the more difficult situation, a commoditized chemistry approach is no longer viable. You really have to ask how do you customize this chemical solution? And Flotek is the best in the business at doing that. That's where I really believe it creates an additional opportunity for us.

Jeff Robertson

analyst
#27

Thank you.

Bond Clement

executive
#28

Thanks, Jeff.

Eric Swergold

analyst
#29

Hello there. Good morning, everyone, and well done on steering ProFrac through such a challenging period. I'd like to hear more about the portion of your business that isn't tied to ProFrac and what limiting factors exist right now. On the chemicals side, you've clearly done a commendable job expanding beyond ProFrac. So what's constraining you today, or does it simply come down to how many sales reps you can put in front of how many buyers? Thank you.

Ryan Ezell

executive
#30

Morning, Eric. First off, when we consider revenue unrelated to ProFrac as a share of Q1, it landed in the 24%-25% range. Coming out of the year, we're seeing that figure at 45%. And throughout the year, that chemistry portion of our business has grown each quarter. Even more significant, the jump from Q1 to Q4 is nearly 200% growth. So we keep pressing ahead when it comes to capturing additional market share. Generally speaking, that sale cycle runs a bit longer, since much of it involves value-add technologies. And we're genuinely beginning to watch that expand. Complex nano fluid sales are rising, and I believe that trend will persist. I wouldn't say it always produces that discontinuity element. Still, there are numerous benefits to what we deliver on the transactional side. My expectation is that it grows right through 2024. Beyond that, JP3 should keep adding meaningfully, since we anticipate 50% growth in 2024 for that as well. I don't believe much is really restraining it. Looking at things today, you'll likely observe frac fleet activity in North America land that is flat to down. What's emerging is a return of what we term tier one customers, where you find sustained programs lasting all year long; those are exactly the customers we're chasing now to get our chemistry embedded and demonstrate the impact across some of these major basins. So this opportunity has us genuinely enthusiastic. In my view, such headwinds present excellent opportunities for strong teams to steer through the wind properly and truly capture additional market share.

Eric Swergold

analyst
#31

Many thanks.

Jeff Robertson

analyst
#32

Appreciate it. To build on that, Bond, now that the material weakness has been removed from the 10-K and we expect positive Adjusted EBITDA across all of 2024, do those improved finances and stronger liquidity help move along your commercial talks, or Flotek's, with customers and prospective partners as you evaluate the opportunities ahead?

Bond Clement

executive
#33

Yes, absolutely, no question about it. I mean, when you're speaking with people and the going concern language is sitting there in your public filings, I think that stirs up some anxiety. So I'd say the going concern is the more important one; we're definitely pleased to have both of them behind us; but putting the going concern behind us, and having our auditors concur that the company's financial outlook is far more stable than it was this time last year, will certainly help us as we negotiate rebates and various items with suppliers and customers.

Jeff Robertson

analyst
#34

Thank you. Thanks for taking my follow-up.

Bond Clement

executive
#35

Thanks.

Richard Rudgley

analyst
#36

Hey there. This is honestly just a fast one. Given how robust your EBITDA looks and the way your strategy is unfolding — and from what I'm hearing, you're plainly projecting optimism — at the same time, though, the market really isn't giving the stock credit. I mean, it's down, I'm not certain, perhaps before today, around 20%+; so you're trading under book value. I was just wondering if you would think about, or have already been thinking about, at least a small stock buyback. Thanks.

Bond Clement

executive
#37

Appreciate the question, Richard. No, not right now. If you consider our work with this company over at least the past year—arguably across the past two years—the focus has genuinely been on steadying operations and moving us toward profitability, which is how we frame it; in that respect, we believe we've clearly reached a turning point. That said, when it comes to repurchasing shares or taking other steps to give cash back to shareholders right now, we're probably not at that stage of maturity as a business. It's definitely something we hope to reach before long. However, as things stand today, there are no plans on our end for buying back stock.

Jeff Robertson

analyst
#38

Alright, got it. Thanks very much.

Ryan Ezell

executive
#39

All right, I want to remind everyone that Flotek will be at the 36th Annual Roth Conference next week, held at the Ritz-Carlton in Dana Point, California. On Monday, March 18th, at 1:00 P.M. Pacific Time, I'll be on an oilfield service panel discussion. During the conference, Bond will join us in hosting one-on-one meetings with investors. We're looking forward to seeing you at the conference next week. Thanks once more for being with us today.

Operator

operator
#40

Thank you, sir. Ladies and gentlemen, that truly brings today's conference call to a close. Thank you once more for joining us. Right now, we kindly ask that you disconnect your lines. Have a good day. You'll be.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.